Personalized Cancer Immunotherapy through DNA-EP vaccines

Project Information

TK-NEO

Grant agreement ID: 874958

DOI 10.3030/874958

Closed project

EC signature date 25 July 2019

Start date 1 August 2019

End date 31 January 2020

Funded under

• INDUSTRIAL LEADERSHIP - Innovation In SMEs

Total cost € 71 429,00

EU contribution € 50 000,00

Coordinated by

TAKIS SRL
Italy